These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Han CS; Miller W; Haake R; Weisdorf D Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570 [TBL] [Abstract][Full Text] [Related]
4. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin). Zintl F; Färber I; Hermann J; Fuchs D; Prager J; Wutzler P Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):557-64. PubMed ID: 2480308 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744 [TBL] [Abstract][Full Text] [Related]
7. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group. Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551 [TBL] [Abstract][Full Text] [Related]
8. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease. Boström L; Ringdén O; Forsgren M Scand J Immunol; 1991 Jul; 34(1):45-52. PubMed ID: 1648786 [TBL] [Abstract][Full Text] [Related]
9. Serum antibody profile against herpesviruses in renal transplant recipients. Carpi C; Donati M; Musiani M; Zerbini M; Cevenini R; Feletti C Boll Ist Sieroter Milan; 1982; 61(3):245-7. PubMed ID: 6100358 [TBL] [Abstract][Full Text] [Related]
10. The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation. de Gast GC; Gratama JW; Verdonck LF; van Heugten JG; Zwaan FE; Phillips DI; Mudde GC Transplantation; 1989 Jul; 48(1):111-5. PubMed ID: 2546299 [TBL] [Abstract][Full Text] [Related]
11. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation. Gratama JW; Verdonck LF; van der Linden JA; van Heugten JG; Kreeft HA; D'Amaro J; Zwaan FE; de Gast GC Transplantation; 1986 Jun; 41(6):719-24. PubMed ID: 3012833 [TBL] [Abstract][Full Text] [Related]
12. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation. Ogunjimi B; Theeten H; Hens N; Beutels P J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981 [TBL] [Abstract][Full Text] [Related]
13. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients]. Merlino C G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971 [TBL] [Abstract][Full Text] [Related]
14. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature. David DS; Tegtmeier BR; O'Donnell MR; Paz IB; McCarty TM Am J Gastroenterol; 1998 May; 93(5):810-3. PubMed ID: 9625133 [TBL] [Abstract][Full Text] [Related]
15. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. Miller WJ; McCullough J; Balfour HH; Haake RJ; Ramsay NK; Goldman A; Bowman R; Kersey J Bone Marrow Transplant; 1991 Mar; 7(3):227-34. PubMed ID: 1647829 [TBL] [Abstract][Full Text] [Related]
16. Influence of cytomegalovirus infection on the recovery of humoral immunity after autologous bone marrow transplantation. Verdonck LF; van der Linden JA; Bast BJ; Gmelig Meyling FH; de Gast GC Exp Hematol; 1987 Sep; 15(8):864-8. PubMed ID: 3040453 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products. Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522 [TBL] [Abstract][Full Text] [Related]
18. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703 [TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients. Cheng FW; Chan PK; Lee V; Leung WK; Shing MK; Li CK; Leung TF Pediatr Transplant; 2010 Sep; 14(6):761-9. PubMed ID: 20534025 [TBL] [Abstract][Full Text] [Related]
20. [Human herpesvirus 6 (HHV-6): incidence in healthy blood donors and in patients with acute infections caused by other herpes viruses]. Larcher C; Huemer HP; Hönlinger M; Margreiter R; Dierich MP Wien Klin Wochenschr; 1989 Jun; 101(13):448-50. PubMed ID: 2548350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]